Diabetic neuropathy is the most common cause of neuropathy in the developed world. It affects 30% to 50% of diabetic patients and it is a considerable source of morbidity and mortality. The new edition of this book is a comprehensive update and addresses the scientific basis of diabetic neuropathy, diabetic trials, and, importantly, the clinical management of the complications of diabetic neuropathy, including those due to pain, joint deformity, infection, and dysautonomia. The list of contributors is substantial and includes basic science researchers and experts in clinical management.
Diabetic Neuropathy: Clinical Management, 2nd ed. Arch Neurol. 2008;65(11):1543. doi:https://doi.org/10.1001/archneur.65.11.1543-a
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: